These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 15726362

  • 21. Autologous stem cell transplantation for Hodgkin's lymphoma: results and prognostic factors in 51 high-risk patients.
    Sperotto A, Damiani D, Zaja F, Patriarca F, Geromin A, Cerno M, Stocchi R, Tiribelli M, Skert C, Rinaldi C, Fanin R.
    Adv Clin Path; 2002 Apr; 6(2):77-85. PubMed ID: 19753729
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma -- a retrospective evaluation.
    Demirer T, Ayli M, Fen T, Ozcan M, Arat M, Buyukberber S, Arslan O, Gurman G, Akan H, Ilhan O.
    Bone Marrow Transplant; 2004 Nov; 34(9):781-6. PubMed ID: 15354206
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Allogeneic transplantation in malignant lymphoma].
    Stötzer OJ, Schleuning M, Ledderose G, Hiddemann W, Kolb HJ.
    Dtsch Med Wochenschr; 2001 Sep 28; 126(39):1062-9. PubMed ID: 11602913
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. High-dose therapy and autologous stem cell transplantation for Hodgkin's lymphoma in relapse or failure after initial chemotherapy : results of the Centre National de Greffe de Moelle Osseuse de Tunis.
    Torjman L, Ladeb S, Lakhal A, Ben Othman T, Abdelkefi A, Ben Abdeladhim A.
    Tunis Med; 2007 Jan 28; 85(1):35-8. PubMed ID: 17424707
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
    Wójcik B, Kowalczyk JR, Chybicka A, Wachowiak J, Drabko K, Zaucha-Prazmo A, Choma M, Gorczyńska E, Toporski J, Turkiewicz D, Kałwak K, Pieczonka A, Boruczkowski D.
    Przegl Lek; 2004 Jan 28; 61 Suppl 2():53-6. PubMed ID: 15686047
    [Abstract] [Full Text] [Related]

  • 34. Autologous stem cell transplantation for high-risk Hodgkin's disease: improvement over time and impact of conditioning regimen.
    Subirà M, Sureda A, Martino R, García J, Altés A, Canals C, Domingo-Albós A, Brunet S, Sierra J.
    Haematologica; 2000 Feb 28; 85(2):167-72. PubMed ID: 10681724
    [Abstract] [Full Text] [Related]

  • 35. Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma.
    Benekli M, Smiley SL, Younis T, Czuczman MS, Hernandez-Ilizaliturri F, Bambach B, Battiwalla M, Padmanabhan S, McCarthy PL, Hahn T.
    Bone Marrow Transplant; 2008 Apr 28; 41(7):613-9. PubMed ID: 18071290
    [Abstract] [Full Text] [Related]

  • 36. [Superhigh-dosage chemotherapy with the transplantation of autologous hemopoietic precursor cells in patients with a prognostically unfavorable relapse and resistant course of lymphogranulomatosis].
    Ptuskin VV, Uss AL, Demina EA, Chervonobab IuV, Milanovich NF, Tupitsyn NN, Larionova VB, Batan ZE, Kondrat'eva NE, Zmachinskiĭ VA, Andreeva LA, Snegir' VM, Mkheidze DM, Chimishkian KL.
    Ter Arkh; 1997 Apr 28; 69(10):49-55. PubMed ID: 9471790
    [Abstract] [Full Text] [Related]

  • 37. Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease.
    Reece DE, Nevill TJ, Sayegh A, Spinelli JJ, Brockington DA, Barnett MJ, Klingemann HG, Connors JM, Nantel SH, Shepherd JD, Sutherland HJ, Voss NJ, Fairey RN, O'Reilly SE, Phillips GL.
    Bone Marrow Transplant; 1999 Jun 28; 23(11):1131-8. PubMed ID: 10382952
    [Abstract] [Full Text] [Related]

  • 38. Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin's disease: retrospective analysis of 158 cases from the French registry.
    Moreau P, Fleury J, Brice P, Colombat P, Bouabdallah R, Lioure B, Voillat L, Casasnovas O, François S, Sadoun A, Lamy T, Lotz JP, Munck JN, Divine M, Fermé C, Pény AM, Fruchart C, Oriol P, Ojeda M, Reman O, Milpied N, Gisselbrecht C, Legros M, Harousseau JL.
    Bone Marrow Transplant; 1998 Apr 28; 21(8):787-93. PubMed ID: 9603402
    [Abstract] [Full Text] [Related]

  • 39. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
    Dann EJ, Daugherty CK, Larson RA.
    Bone Marrow Transplant; 1997 Sep 28; 20(5):369-74. PubMed ID: 9339751
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.